AstraZeneca stock dives 9% after heart drug trial misses target

July 9, 2026 DG Health & Wellness News

In this article AZN IONS ALNY Follow your favorite stocksCREATE FREE ACCOUNT Shares of AstraZeneca fell as much as 9% after a late-stage clinical trial

Tag: heart

AstraZeneca stock dives 9% after heart drug trial misses target

Jim Cramer says these are the 5 stocks to buy during this market rotation

The Genes That Could Cancel Out a Fatal Diagnosis

Lab-Leak Payback Has Begun

Healthy Returns: Employers aren’t expanding coverage of GLP-1 obesity drugs — many are finding ways around it

Extreme Dizziness, No Headache: The Migraine Many Doctors Miss

4 Prepable, Nutrient-Rich Salads

Should I Be Taking Psyllium Husk?